HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsutomu Takeuchi Selected Research

Tsutomu Takeuchi Research Topics

Disease

263Rheumatoid Arthritis
11/2022 - 06/2003
46Infections
07/2022 - 08/2002
22Immunoglobulin G4-Related Disease
07/2022 - 01/2012
22Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 09/2003
21Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 09/2005
17Herpes Zoster
07/2022 - 01/2016
15Rheumatic Diseases (Rheumatism)
04/2022 - 01/2007
14Autoimmune Diseases (Autoimmune Disease)
01/2022 - 08/2005
13Inflammation (Inflammations)
05/2022 - 08/2003
11Necrosis
01/2021 - 07/2011
10Neoplasms (Cancer)
05/2022 - 12/2002
9Lupus Nephritis
07/2022 - 01/2007
9Arthritis (Polyarthritis)
01/2022 - 01/2006
9Adult-Onset Still's Disease
01/2022 - 03/2012
9Fever (Fevers)
05/2021 - 09/2005
9Pain (Aches)
01/2021 - 05/2012
9Cysts
06/2012 - 09/2002
8Pneumonia (Pneumonitis)
03/2021 - 01/2007
7Opportunistic Infections (Opportunistic Infection)
01/2021 - 01/2005
7Drug-Related Side Effects and Adverse Reactions
05/2020 - 11/2010
7Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
11/2012 - 01/2007
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022 - 02/2007
6Systemic Scleroderma (Systemic Sclerosis)
10/2021 - 01/2007
6Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
10/2021 - 01/2015
5Vasculitis (Vasculitides)
07/2022 - 01/2021
5Connective Tissue Diseases (Connective Tissue Disease)
11/2021 - 03/2013
5Disease Progression
11/2021 - 12/2017
5Myositis (Idiopathic Inflammatory Myopathies)
01/2021 - 09/2005
5Nasopharyngitis
01/2019 - 06/2016
5Arthralgia (Joint Pain)
11/2018 - 07/2011
5Amebiasis (Amoebiasis)
02/2006 - 08/2003
4Psoriatic Arthritis
07/2022 - 08/2017
4Dermatomyositis (Dermatopolymyositis)
01/2022 - 09/2005
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2021 - 01/2020
4Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2021 - 08/2017
4Mixed Connective Tissue Disease (MCTD)
01/2021 - 10/2012
4Joint Diseases (Joint Disease)
12/2017 - 10/2013
4Communicable Diseases (Infectious Diseases)
01/2016 - 10/2003
4Lung Diseases (Lung Disease)
10/2015 - 11/2012

Drug/Important Bio-Agent (IBA)

81Methotrexate (Mexate)FDA LinkGeneric
11/2022 - 12/2004
44Biological ProductsIBA
05/2022 - 01/2005
43tocilizumab (atlizumab)FDA Link
10/2022 - 09/2007
34Infliximab (Remicade)FDA Link
07/2022 - 01/2005
31Antirheumatic Agents (DMARD)IBA
11/2021 - 01/2006
28GlucocorticoidsIBA
01/2022 - 02/2003
26Adalimumab (Humira)FDA Link
02/2022 - 06/2012
24Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2004
24Monoclonal AntibodiesIBA
07/2021 - 10/2003
21Immunoglobulin G (IgG)IBA
07/2022 - 01/2005
21Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2009
21Etanercept (Enbrel)FDA Link
03/2021 - 12/2002
20Abatacept (Orencia)FDA Link
04/2022 - 03/2013
18CytokinesIBA
01/2022 - 02/2003
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022 - 01/2005
16Pharmaceutical PreparationsIBA
02/2022 - 10/2002
15baricitinibIBA
01/2022 - 01/2017
14C-Reactive ProteinIBA
05/2021 - 01/2008
13Janus Kinase InhibitorsIBA
07/2022 - 01/2016
12InterleukinsIBA
01/2022 - 11/2013
12Prednisolone (Predate)FDA LinkGeneric
01/2022 - 09/2005
12AutoantibodiesIBA
05/2021 - 01/2011
11peficitinibIBA
07/2022 - 06/2016
11AntibodiesIBA
01/2021 - 02/2003
11Certolizumab PegolFDA Link
03/2020 - 07/2014
11Adrenal Cortex Hormones (Corticosteroids)IBA
09/2019 - 09/2005
11EnzymesIBA
11/2018 - 01/2004
10Tacrolimus (Prograf)FDA LinkGeneric
11/2021 - 02/2009
10Tumor Necrosis Factor InhibitorsIBA
07/2021 - 07/2011
9Rituximab (Mabthera)FDA Link
01/2022 - 01/2007
9Proteins (Proteins, Gene)FDA Link
05/2021 - 03/2002
8tofacitinibIBA
10/2022 - 07/2015
8Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2021 - 01/2011
7GLPG0634IBA
04/2022 - 01/2019
7DenosumabFDA Link
11/2021 - 06/2016
7sirukumabIBA
01/2021 - 06/2017
7golimumabFDA Link
01/2020 - 06/2012
7Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2020 - 01/2009
6Immunosuppressive Agents (Immunosuppressants)IBA
11/2021 - 06/2005
6upadacitinibIBA
06/2021 - 01/2020
6AntigensIBA
01/2021 - 03/2004
6Janus KinasesIBA
10/2020 - 06/2017
6Messenger RNA (mRNA)IBA
06/2012 - 09/2003
5omega-Chloroacetophenone (Mace)IBA
04/2022 - 01/2019
5SteroidsIBA
01/2022 - 05/2015
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021 - 09/2005
5Leflunomide (Arava)FDA LinkGeneric
01/2020 - 01/2008
4Biosimilar PharmaceuticalsIBA
07/2022 - 06/2017
4Interleukin-4 (Interleukin 4)IBA
01/2022 - 09/2010
4Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2021 - 09/2005
4ametantrone (HAQ)IBA
01/2021 - 01/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2003
4Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2020 - 10/2013
4beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2020 - 10/2012
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2018 - 07/2011
4zeta chain antigen T cell receptor (TCR zeta chain)IBA
08/2005 - 09/2003
3CT-P13IBA
07/2022 - 01/2015
3Anti-Citrullinated Protein AntibodiesIBA
04/2022 - 06/2014

Therapy/Procedure

83Therapeutics
11/2022 - 08/2002
4Aftercare (After-Treatment)
05/2018 - 01/2011
4Biological Therapy
05/2015 - 11/2010